【药物名称】Technetim (99mTc) tiatide, Technetium (99mTc) mertiatide, MAG3-[99mTc], [99mTc]-MAG3, MAGscinti, Technescan MAG3
化学结构式(Chemical Structure):
参考文献No.8341
标题:Radiolabeled technetium chelates for use in renal function determinations
作者:Fritzburg, A. (University of Utah)
来源:EP 0173424
合成路线图解说明:

The benzoyl-protected ligand (IV) was prepared as follows. Acylation of triglycine (I) with chloroacetyl chloride (II) produced the chloroacetamide (III). Subsequent treatment of chloride (III) with sodium thiobenzoate yielded thioester (IV). The title 99technetium complex was prepared by in situ hydrolysis of the thiobenzoate ester (IV) to mercaptoacetyl triglycine (V) in the presence of a solution of [99mTc]pertechnetate, SnCl2 as the technetium reducing species, and gluconate or tartrate as intermediate Tc complexing agents.

参考文献No.67612
标题:Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement
作者:Fritzberg, A.R.; Kasina, S.; Eshima, D.; Johnson, D.L.
来源:J Nucl Med 1986,27(1),111
合成路线图解说明:

The benzoyl-protected ligand (IV) was prepared as follows. Acylation of triglycine (I) with chloroacetyl chloride (II) produced the chloroacetamide (III). Subsequent treatment of chloride (III) with sodium thiobenzoate yielded thioester (IV). The title 99technetium complex was prepared by in situ hydrolysis of the thiobenzoate ester (IV) to mercaptoacetyl triglycine (V) in the presence of a solution of [99mTc]pertechnetate, SnCl2 as the technetium reducing species, and gluconate or tartrate as intermediate Tc complexing agents.

参考文献No.67619
标题:Technetium-99m labeled renal function and imaging agents. 3. Synthesis of Tc-99m-MAG3 and biodistribution of by-products
作者:Brandau, W.; et al.
来源:Int J Radiat Appl Instrum Part A - Appl Radiat Isotop 1988,39(2),121
合成路线图解说明:

The benzoyl-protected ligand (IV) was prepared as follows. Acylation of triglycine (I) with chloroacetyl chloride (II) produced the chloroacetamide (III). Subsequent treatment of chloride (III) with sodium thiobenzoate yielded thioester (IV). The title 99technetium complex was prepared by in situ hydrolysis of the thiobenzoate ester (IV) to mercaptoacetyl triglycine (V) in the presence of a solution of [99mTc]pertechnetate, SnCl2 as the technetium reducing species, and gluconate or tartrate as intermediate Tc complexing agents.

合成路线图解说明:

The protected ligand (IV) was also prepared by a related method. The acylation of thioglycolic acid (V) with benzoyl chloride (VI) under Schotten-Baumann conditions afforded S-benzoyl thioglycolic acid (VII). After activation of (VII) as the corresponding succinimidyl ester (VIII) with N-hydroxysuccinimide and DCC, coupling with triglycine (I) furnished compound (IV).

参考文献No.702462
标题:Investigation of the labelling characteristics of 99mTc-mercaptoacetyltriglycine
作者:Bormans, G.; Cleynhens, B.; Adriaens, P.; Vanbilloen, H.; De Roo, M.; Verbruggen, A.
来源:Nucl Med Biol 1995,22(3),339
合成路线图解说明:

Other S-protecting groups for mercaptoacetyl triglycine have been reported. The S-benzyl derivative (X) was prepared by condensation of triglycine (I) with (benzylthio)acetyl chloride (IX). Alternatively, the S-benzamidomethyl compound (XII) was prepared as follows. Thioglycolic acid (V) was condensed with benzamidomethanol under acidic conditions to give S-(benzamidomethyl)thioglycolic acid (XI), which was then coupled to triglycine (I) using DCC/HOBt. Deprotection in the presence of 99Tc pertechnetate under the same conditions as above furnished the title Tc complex.

参考文献No.702463
标题:Comparison of the labelling characteristics of mercaptoacetyltriglycine (MAG3) with different S-protective groups
作者:Okarvi, S.M.; et al.
来源:J Label Compd Radiopharm 1997,39(10),853
合成路线图解说明:

Other S-protecting groups for mercaptoacetyl triglycine have been reported. The S-benzyl derivative (X) was prepared by condensation of triglycine (I) with (benzylthio)acetyl chloride (IX). Alternatively, the S-benzamidomethyl compound (XII) was prepared as follows. Thioglycolic acid (V) was condensed with benzamidomethanol under acidic conditions to give S-(benzamidomethyl)thioglycolic acid (XI), which was then coupled to triglycine (I) using DCC/HOBt. Deprotection in the presence of 99Tc pertechnetate under the same conditions as above furnished the title Tc complex.

参考文献No.702465
标题:Rapid preparation and quality control of technetium-99m MAG3(TM)
作者:Hung, J.C.; et al.
来源:J Nucl Med Technol 1991,19(3),176
合成路线图解说明:

The benzoyl-protected ligand (IV) was prepared as follows. Acylation of triglycine (I) with chloroacetyl chloride (II) produced the chloroacetamide (III). Subsequent treatment of chloride (III) with sodium thiobenzoate yielded thioester (IV). The title 99technetium complex was prepared by in situ hydrolysis of the thiobenzoate ester (IV) to mercaptoacetyl triglycine (V) in the presence of a solution of [99mTc]pertechnetate, SnCl2 as the technetium reducing species, and gluconate or tartrate as intermediate Tc complexing agents.

参考文献No.702466
标题:An alkaline kit formulation to obtain [99mTc]MAG3 in high radiochemical yields
作者:Reyes-Herrera, L.; et al.
来源:J Radioanal Nucl Chem 1995,199(6),507
合成路线图解说明:

The benzoyl-protected ligand (IV) was prepared as follows. Acylation of triglycine (I) with chloroacetyl chloride (II) produced the chloroacetamide (III). Subsequent treatment of chloride (III) with sodium thiobenzoate yielded thioester (IV). The title 99technetium complex was prepared by in situ hydrolysis of the thiobenzoate ester (IV) to mercaptoacetyl triglycine (V) in the presence of a solution of [99mTc]pertechnetate, SnCl2 as the technetium reducing species, and gluconate or tartrate as intermediate Tc complexing agents.

参考文献No.702467
标题:Synthesis, characterization and crystal structures of technetium(V)-oxo complexes useful in nuclear medicine. 1. Complexes of mercaptoacetylglycylglycylglycine (MAG3) and its methyl ester derivative (MAG3OMe)
作者:Grummon, G.; et al.
来源:Inorg Chem 1995,34(7),1764
合成路线图解说明:

The benzoyl-protected ligand (IV) was prepared as follows. Acylation of triglycine (I) with chloroacetyl chloride (II) produced the chloroacetamide (III). Subsequent treatment of chloride (III) with sodium thiobenzoate yielded thioester (IV). The title 99technetium complex was prepared by in situ hydrolysis of the thiobenzoate ester (IV) to mercaptoacetyl triglycine (V) in the presence of a solution of [99mTc]pertechnetate, SnCl2 as the technetium reducing species, and gluconate or tartrate as intermediate Tc complexing agents.

合成路线图解说明:

The protected ligand (IV) was also prepared by a related method. The acylation of thioglycolic acid (V) with benzoyl chloride (VI) under Schotten-Baumann conditions afforded S-benzoyl thioglycolic acid (VII). After activation of (VII) as the corresponding succinimidyl ester (VIII) with N-hydroxysuccinimide and DCC, coupling with triglycine (I) furnished compound (IV).

Drug Information Express,Drug R&D,Chemical Database,Patent Search.
Copyright © 2006-2024 Drug Future. All rights reserved.Contact Us